An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine
Status:
Completed
Trial end date:
2016-10-12
Target enrollment:
Participant gender:
Summary
This is an observational study to describe the long term use of Onabotulinumtoxin A (BOTOX®)
as prescribed by the physician for headache prophylaxis in adults with chronic migraine. All
treatment decisions lie with the physician.
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA